Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Rhea-AI Summary

Quantum-Si Incorporated (NASDAQ: QSI) announced its participation in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. CEO John Stark and CFO Claudia Drayton will engage in a virtual fireside chat on Thursday, November 18, 2021, at 2:30 p.m. ET. Interested parties can access a webcast on the Investors section of Quantum-Si's website, with a replay available post-event. Founded in 2013 by Dr. Jonathan Rothberg, Quantum-Si focuses on advancing proteomics through its unique protein sequencing technology powered by a groundbreaking semiconductor chip.

GUILFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.

A webcast of the event will be available on the Investors section of Quantum-Si’s website under Events & Presentations. A replay will be available on the Company’s website after the event.

About Quantum-Si

Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211104006292/en/

Investor Contacts

Juan Avendano

VP of Investor Relations

(413) 537-8735

javendano@quantum-si.com



Mike Cavanaugh

ICR Westwicke

(617) 877-9641

ir@quantum-si.com



Media Contact

Cammy Duong

ICR Westwicke

(203) 682-8380

QSI-PR@westwicke.com

Source: Quantum-Si Incorporated

FAQ

What is Quantum-Si's participation in the Canaccord Genuity Virtual Forum?

Quantum-Si (NASDAQ: QSI) will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum with a fireside chat on November 18, 2021.

Who will represent Quantum-Si during the virtual fireside chat?

CEO John Stark and CFO Claudia Drayton will represent Quantum-Si at the virtual fireside chat.

When will Quantum-Si's fireside chat take place?

The fireside chat will take place on November 18, 2021, at 2:30 p.m. ET.

How can I access the webcast of Quantum-Si's participation in the forum?

The webcast will be available on the Investors section of Quantum-Si's website, and a replay will be accessible after the event.

What technology does Quantum-Si focus on in proteomics?

Quantum-Si specializes in protein sequencing technology using a unique semiconductor chip for next-generation sequencing in proteomics.